Clinical Trials in China / NCT07488325
Recruiting
Observational
Multimodal Assessment of Malignancy in Atypia of Undetermined Significance in Thyroid Nodules Using Ultrasound and Cytology Whole-Slide Images
NCT07488325 · tracked via the Priya Life Science China tracker
Condition(s) studied
Thyroid Nodule
Investigational drug(s) / intervention(s)
Histopathology or cytopathology.
Histopathology or cytopathology.: This is a observation stufy.
Study summary
The prospective study aim to develop a multimodal deep learning model that integrates ultrasound images and cytological whole-slide images for more accurate malignant risk prediction of Bethesda III thyroid nodules.
Eligibility
Inclusion Criteria:
* (a) Patients who underwent fine-needle aspiration of thyroid nodules and received a cytological diagnosis of Bethesda Ⅲ.
* (b) Patients who subsequently underwent thyroid surgery with a definitive histopathological diagnosis of benign or malignant lesions,.
* (c) Availability of at least one ultrasound image acquired prior to surgery.
Exclusion Criteria:
* (a) Patients without confirmation by surgical pathology,.
* (b) Patients without any available or usable ultrasound images.
Primary outcome measure(s)
- Pathological diagnosis. — One month after the surgery.
WHO guidelines.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| No. 33 Yingfeng Road, Haizhu District, Guangzhou City, Guangdong Province, Sun Yat-sen Memorial Hospital | Guangzhou | Guangzhou | Recruiting |
More Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University trials in China
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07488325 on ClinicalTrials.gov ↗ ← All trials in China